About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
IOL Chemicals And Pharmaceuticals Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
06-May-2025
16-May-2025
Quarterly Results & Audited Results
04-Feb-2025
12-Feb-2025
Quarterly Results & Interim Dividend
18-Dec-2024
27-Dec-2024
Stock Split Inter-alia to consider and approve the alteration in the share capital of the Company by sub-division / split of existing equity shares having face value of Rs. 10/- each, fully paid up, as may be determined by the Board of Directors.
05-Nov-2024
14-Nov-2024
Quarterly Results
30-Jul-2024
09-Aug-2024
Quarterly Results
06-May-2024
14-May-2024
Audited Results
29-Jan-2024
06-Feb-2024
Quarterly Results & Interim Dividend
30-Oct-2023
08-Nov-2023
Quarterly Results
03-Aug-2023
09-Aug-2023
Quarterly Results
21-Apr-2023
28-Apr-2023
Audited Results & Quarterly Results
01-Feb-2023
07-Feb-2023
Interim Dividend & Audited Results
03-Nov-2022
14-Nov-2022
Quarterly Results
29-Jul-2022
09-Aug-2022
Quarterly Results
23-May-2022
30-May-2022
Quarterly Results
28-Jan-2022
04-Feb-2022
Quarterly Results & Interim Dividend
03-Nov-2021
12-Nov-2021
Quarterly Results
06-Aug-2021
13-Aug-2021
Quarterly Results
26-May-2021
04-Jun-2021
Audited Results
02-Feb-2021
10-Feb-2021
Quarterly Results
30-Oct-2020
06-Nov-2020
Interim Dividend & Quarterly Results
Page
1
of
6
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.